News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
455,461 Results
Type
Article (23878)
Company Profile (156)
Press Release (431427)
Section
Business (144937)
Career Advice (1323)
Deals (25958)
Drug Delivery (102)
Drug Development (54716)
Employer Resources (99)
FDA (10032)
Job Trends (11155)
News (242022)
Policy (23594)
Tag
Academia (1384)
Alliances (38772)
Alzheimer's disease (765)
Approvals (10036)
Artificial intelligence (165)
Bankruptcy (233)
Best Places to Work (8570)
Breast cancer (129)
Cancer (1133)
Cardiovascular disease (97)
Career advice (1081)
Cell therapy (199)
Clinical research (45142)
Collaboration (505)
Compensation (254)
COVID-19 (1651)
C-suite (130)
Data (1074)
Diabetes (141)
Diagnostics (4117)
Drug pricing (113)
Earnings (52502)
Employer resources (90)
Events (63834)
Executive appointments (472)
FDA (10649)
Funding (364)
Gene therapy (153)
GLP-1 (582)
Government (3321)
Healthcare (12240)
Infectious disease (1743)
Inflammatory bowel disease (94)
Interviews (194)
IPO (10636)
Job creations (2919)
Job search strategy (953)
Layoffs (312)
Legal (5610)
Lung cancer (164)
Manufacturing (208)
Medical device (6276)
Medtech (6279)
Mergers & acquisitions (15610)
Metabolic disorders (449)
Neuroscience (1052)
NextGen: Class of 2025 (4554)
Non-profit (2898)
Northern California (1189)
Obesity (272)
Opinion (204)
Patents (126)
People (44546)
Phase I (14000)
Phase II (19240)
Phase III (15359)
Pipeline (578)
Policy (107)
Postmarket research (1773)
Preclinical (5016)
Radiopharmaceuticals (181)
Rare diseases (236)
Real estate (4768)
Regulatory (15977)
Research institute (1295)
Resumes & cover letters (209)
Southern California (1113)
Startups (2491)
United States (11720)
Vaccines (351)
Weight loss (225)
Date
Today (158)
Last 7 days (481)
Last 30 days (1900)
Last 365 days (22799)
2025 (3385)
2024 (23130)
2023 (26053)
2022 (34789)
2021 (37284)
2020 (36951)
2019 (33181)
2018 (25475)
2017 (22728)
2016 (21711)
2015 (24934)
2014 (19367)
2013 (16396)
2012 (17758)
2011 (18357)
2010 (16660)
Location
Africa (540)
Arizona (99)
Asia (29506)
Australia (3923)
California (2805)
Canada (1341)
China (302)
Colorado (151)
Connecticut (149)
Europe (63182)
Florida (458)
Illinois (345)
Indiana (200)
Japan (102)
Maryland (543)
Massachusetts (2192)
Michigan (105)
Minnesota (175)
New Jersey (1074)
New York (792)
North Carolina (633)
Northern California (1189)
Ohio (130)
Pennsylvania (694)
South America (801)
Southern California (1113)
Texas (439)
Virginia (92)
Washington State (248)
455,461 Results for "johnson matthey pharma services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m
Johnson Matthey Plc (JM) announces that it has signed a definitive agreement to sell 100% of its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for cash consideration of US$700 million (£550 million) on a cash free debt free basis.
March 20, 2024
·
4 min read
Government
Trump’s Whiplash Policies Keep Pharmas on Their Toes
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives find themselves faced with policy questions ranging from the Inflation Reduction Act to RFK Jr.
February 12, 2025
·
4 min read
·
Annalee Armstrong
Business
Deep Dive: JPM M&A Rush Just the Start, as Biopharma Insider Predicts Mega-Deals to Come
The J.P. Morgan Healthcare Conference started off with a flurry of deals that reinvigorated excitement across the biopharma industry. Johnson & Johnson moved to acquire Intra-Cellular Therapies for $14.6 billion, breaking a dealmaking barrier that kept Big Pharma’s 2024 biotech buyouts to under $5 billion.
January 29, 2025
·
1 min read
·
Annalee Armstrong
GLP-1
Lilly, Novo Skew Overall Pharma Trends With Colossal GLP-1 Sales Growth
From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved into a new pharma stratosphere, far eclipsing their rivals.
February 12, 2025
·
2 min read
·
Annalee Armstrong
Government
Trump Threatens Big Pharma With Tariffs—Unless They Reshore Manufacturing: Bloomberg
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
February 24, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Johnson & Johnson Makes Major Neuro Play With $14.6B Intra-Cellular Buyout
Among Intra-Cellular’s neuropsychiatric assets is Caplyta, a pill approved for schizophrenia and bipolar depression and proposed for major depressive disorder.
January 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
CiteAb announces Unlimited service, a 14m strong licensable reagent collective, to accelerate pharma R&D
February 26, 2025
·
1 min read
Press Releases
Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference
February 3, 2025
·
1 min read
Press Releases
Johnson & Johnson Reports Q4 and Full-Year 2024 Results
January 23, 2025
·
19 min read
Deals
Johnson & Johnson Completes Acquisition of Shockwave Medical
Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson MedTech.
May 31, 2024
·
5 min read
1 of 45,547
Next
